Timothy Cody Ashby

21PUBLICATIONS
76CO-AUTHORS
Medical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jun 09, 2025
Polyclonal plasma cell (PolyPC) signature as a key indicator for predicting the progression of MGUS to multiple myeloma.

Fumou Sun, Yan Cheng, Catherine Ma

|Nov 06, 2024
Multi-omics reveal immune microenvironment alterations in multiple myeloma and its precursor stages.

Yan Cheng, Fumou Sun, Daisy V Alapat

|Jan 19, 2024
Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growth.

Fumou Sun, Yan Cheng, Visanu Wanchai

|Aug 03, 2022
The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states.

Leo Rasche, Carolina Schinke, Francesco Maura

|May 31, 2022
Structural variants shape the genomic landscape and clinical outcome of multiple myeloma.

Cody Ashby, Eileen M Boyle, Michael A Bauer

|May 06, 2022
Myeloma Genome Project Panel is a Comprehensive Targeted Genomics Panel for Molecular Profiling of Patients with Multiple Myeloma.

Parvathi Sudha, Aarif Ahsan, Cody Ashby

Pageof 4

Frequent Collaborators

12 joint publications

Brian A Walker

9 joint publications

Caroline Schinke

8 joint publications

Michael Bauer

8 joint publications

Gareth J Morgan